2,473
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: Prostate Cancer

Sperm preservation and neutron contamination following proton therapy for prostate cancer study

, , , , , , , , , & show all
Pages 17-20 | Received 03 Mar 2016, Accepted 17 Jun 2016, Published online: 15 Jul 2016

References

  • Lin DW, Porter M, Montgomery B. Treatment and survival outcomes in young men diagnosed with prostate cancer: a population-based cohort study. Cancer 2009;115:2863–71.
  • Sidana A, Hernandez DJ, Feng Z, et al. Treatment decision-making for localized prostate cancer: what younger men choose and why. Prostate 2012;72:58–64.
  • Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008;358:1250–61.
  • Chung CS, Yock TI, Nelson K, et al. Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys 2013;87:46–52.
  • Fontenot JD, Lee AK, Newhauser WD. Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer. Int J Radiat Oncol Biol Phys 2009;74:616–22.
  • Hoppe BS, Nichols RC, Henderson RH, Morris CG, Williams CR, Costa J, et al. Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger. Cancer 2012;118:4619–26.
  • Nichols RC, Jr., Morris CG, Hoppe BS, et al. Proton radiotherapy for prostate cancer is not associated with post-treatment testosterone suppression. Int J Radiat Oncol Biol Phys 2012;82:1222–6.
  • Kil WJ, Nichols RC, Jr., Hoppe BS, et al. Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression. Acta Oncol 2013;52:492–7.
  • King CR, Maxim PG, Hsu A, et al. Incidental testicular irradiation from prostate IMRT: it all adds up. Int J Radiat Oncol Biol Phys 2010;77:484–9.
  • Hansen PV, Trykker H, Svennekjaer IL, et al. Long-term recovery of spermatogenesis after radiotherapy in patients with testicular cancer. Radiother Oncol 1990;18:117–25.
  • Centola GM, Keller JW, Henzler M, et al. Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J Androl 1994;15:608–13.
  • Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 2006;65:1–7.
  • Mendenhall NP, Li Z, Hoppe BS, et al. Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2012;82:213–21.
  • Grocela J, Mauceri T, Zietman A. New life after prostate brachytherapy? Considering the fertile female partner of the brachytherapy patient. BJU Int 2005;96:781–2.
  • Steinsvik EA, Fossa SD, Lilleby W, et al. Fertility issues in patients with prostate cancer. BJU Int 2008;102:793–5.
  • Zagars GK, Pollack A. Serum testosterone levels after external beam radiation for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1997;39:85–9.
  • Nichols R, George A, Bahary J, et al. Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on RTOG 9408 [abstract]. Int J Radiat Oncol Biol Phys 2013;87:125–6.
  • Shin D, Yoon M, Kwak J, et al. Secondary neutron doses for several beam configurations for proton therapy. Int J Radiat Oncol Biol Phys 2009;74:260–5.